Fucosylation-deficient cells

Details for Australian Patent Application No. 2012100020 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Chen, Gang; Burakov, Darya; Fandl, James P.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012100020

Parent 2010256753

Filing date 9 January 2012

Opi date 9 February 2012

International Classifications

C12N 15/53 (2006.01) Mutation or genetic engineering - Oxidoreductases (1)

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/04 (2006.01) Enzymes, e.g. ligases (6.) - acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)

C12P 21/00 (2006.01) Preparation of peptides or proteins

Event Publications

2 February 2012 Innovation Patent Application Filed

9 February 2012 Innovation Patent Open to Public Inspection

  Published as AU-A-2012100020

9 February 2012 Innovation Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012100021-Cavitation tube sparging system

2012100019-Silica-stabilized ultrafine anatase titania, vanadia catalysts, and methods of production thereof